全文获取类型
收费全文 | 22939篇 |
免费 | 2446篇 |
国内免费 | 659篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 476篇 |
妇产科学 | 1760篇 |
基础医学 | 5114篇 |
口腔科学 | 244篇 |
临床医学 | 1680篇 |
内科学 | 2917篇 |
皮肤病学 | 457篇 |
神经病学 | 605篇 |
特种医学 | 288篇 |
外国民族医学 | 4篇 |
外科学 | 2922篇 |
综合类 | 3376篇 |
一般理论 | 6篇 |
预防医学 | 1420篇 |
眼科学 | 235篇 |
药学 | 1533篇 |
11篇 | |
中国医学 | 1472篇 |
肿瘤学 | 1469篇 |
出版年
2024年 | 29篇 |
2023年 | 621篇 |
2022年 | 575篇 |
2021年 | 1313篇 |
2020年 | 1243篇 |
2019年 | 989篇 |
2018年 | 812篇 |
2017年 | 1022篇 |
2016年 | 973篇 |
2015年 | 857篇 |
2014年 | 1291篇 |
2013年 | 1747篇 |
2012年 | 1180篇 |
2011年 | 1146篇 |
2010年 | 1032篇 |
2009年 | 947篇 |
2008年 | 892篇 |
2007年 | 927篇 |
2006年 | 947篇 |
2005年 | 795篇 |
2004年 | 716篇 |
2003年 | 669篇 |
2002年 | 634篇 |
2001年 | 532篇 |
2000年 | 436篇 |
1999年 | 384篇 |
1998年 | 303篇 |
1997年 | 268篇 |
1996年 | 273篇 |
1995年 | 286篇 |
1994年 | 240篇 |
1993年 | 202篇 |
1992年 | 181篇 |
1991年 | 211篇 |
1990年 | 134篇 |
1989年 | 133篇 |
1988年 | 145篇 |
1987年 | 144篇 |
1986年 | 104篇 |
1985年 | 131篇 |
1984年 | 132篇 |
1983年 | 86篇 |
1982年 | 106篇 |
1981年 | 66篇 |
1980年 | 60篇 |
1979年 | 49篇 |
1978年 | 24篇 |
1977年 | 18篇 |
1976年 | 19篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):327-334.e2
ObjectiveSeveral trials have recently reported the safety of pulmonary resection after neoadjuvant immunotherapy with encouraging major pathological response rates. We report the detailed adverse events profile from a recently conducted randomized phase II trial in patients with resectable non–small cell lung cancer treated with neoadjuvant durvalumab alone or with sub-ablative radiation.MethodsWe conducted a randomized phase II trial in patients with non–small cell lung cancer clinical stages I to IIIA who were randomly assigned to receive neoadjuvant durvalumab alone or with sub-ablative radiation (8Gyx3). Secondary end points included the safety of 2 cycles of preoperative durvalumab with and without radiation followed by pulmonary resection. Postoperative adverse events within 30 days were recorded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (version 4.0).ResultsSixty patients were enrolled and randomly assigned, with planned resection performed in 26 patients in each arm. Baseline demographics and clinical variables were balanced between groups. The median operative time was similar between arms: 128 minutes (97-201) versus 146 minutes (109-214) (P = .314). There was no 30- or 90-day mortality. Grade 3/4 adverse events occurred in 10 of 26 patients (38%) after monotherapy and in 10 of 26 patients (38%) after dual therapy. Anemia requiring transfusion and hypotension were the 2 most common adverse events. The median length of stay was similar between arms (5 days vs 4 days, P = .172).ConclusionsIn this randomized trial, the addition of sub-ablative focal radiation to durvalumab in the neoadjuvant setting was not associated with increased mortality or morbidity compared with neoadjuvant durvalumab alone. 相似文献
2.
3.
4.
目的研究大黄附子汤对重症急性胰腺炎(SAP)小鼠肠道微皱褶细胞(M细胞)变化的影响,为大黄附子汤临床防治SAP提供理论基础。 方法选取40只健康SPF级C57BL/6J雄性小鼠,随机分为4组(每组10只):空白对照组、大黄附子汤对照组、SAP组、大黄附子汤治疗组,其中SAP组和大黄附子汤治疗组分别以3.5 g/kg剂量腹腔注射20% L-精氨酸,空白对照组和大黄附子汤对照组注射等剂量的等渗盐水;于造模后12、24、36 h,空白对照组和SAP组给予等渗盐水0.2 mL,大黄附子汤对照组和治疗组给予大黄附子汤0.2 mL灌肠,均于造模完成48 h后处死取材,使用ELISA检测血清淀粉酶、内毒素、IL-1β及TNF-α含量,取回肠及胰腺组织行HE染色、评分,免疫组化染色检测M细胞特异性蛋白GP2并评分。 结果(1)一般情况:对照组腹腔注射后小鼠一般情况好,精神状态良好,能正常进水,四肢活动自如,行动未受影响;SAP组小鼠腹腔注射后一般情况差,精神萎靡,反应迟钝,行动迟缓,呼吸急促,拱背收腹,饮水减少。(2)SAP组淀粉酶、内毒素、IL-1β及TNF-α水平较对照组明显升高(P<0.05);与SAP组进行对比,大黄附子汤治疗组血清淀粉酶、内毒素、IL-1β及TNF-α水平出现显著下降(P<0.05)。(3)HE染色:SAP组胰腺及回肠组织坏死严重,可见大量白细胞浸润。大黄附子汤治疗组胰腺及回肠组织轻度坏死,可见少量中性粒细胞等白细胞浸润。(4)免疫组化染色:SAP组与对照组相比GP2表达降低(P<0.05);相较于SAP组,大黄附子汤治疗组GP2的表达水平升高(P<0.05)。 结论大黄附子汤治疗可改善作为肠道免疫应答起始的M细胞数量与功能,增强肠道免疫应答,减轻肠免疫屏障损伤,减少内毒素入血,改善SAP症状。 相似文献
5.
6.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(4):621-624
ObjectivesRecurrent Aphthous Stomatitis (RAS) a chronic idiopathic oral mucosal disease. But yet the etiology and pathogenesis of RAS are not exactly known, it is thought that inflammation play an important role in the pathogenesis. The aim of this study is to demonstrate the role of systemic inflammation among the possible etiological factors of RAS and to find the possible diagnostic correlation between Systemic Immune Inflammation Index (SII).MethodsPatients who were consulted the otolaryngology outpatient clinic and diagnosed with RAS between 2019–2021 were retrospectively analyzed. Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and SII values were calculated based on the results of complete blood count. Demographic and hematological parameters between control and RAS groups were compared. The statistical significance level was considered as <0.05.ResultsThere was no statistically significant difference between the control and RAS groups in terms of sex and age distributions (p = 0.566 and p = 0.173, respectively). SII, NLR and PLR values were significantly higher in the RAS group compared to the controls (p < 0.001, p < 0.001 and p = 0.001, respectively). A very strong correlation between SII and NLR, moderately strong correlation between SII and PLR and moderate correlation between NLR and PLR values were detected (respectively ρ: 0.813, 0.719, 0.532; p-values <0.001).ConclusionSII, NLR and PLR has significantly higher levels in the RAS group compared to the control group, that it supports the role of systemic inflammation in the etiopathogenesis of RAS. In addition, the results show that SII is a valuable marker for inflammation.Level of evidence4. 相似文献
7.
BackgroundBurnout and psychological immune competency have not been investigated together among employees of high-risk specializations such as emergency medicine, intensive care or surgery.AimIn this study we aim to examine the prevalence of burnout among high-risk clinical staff and explore whether the strength of psychological immune competency predict burnout.DesignA cross-sectional design utilizing a self-administrated questionnaire was used to collect data from the participants (n = 216). Nurses (n = 145) and physicians (n = 71) from emergency medicine, intensive care and surgery departments participated in the study.MethodBurnout syndrome was measured using the Maslach Burnout Inventory, while psychological immune competency was measured using the Psychological Immune Competency Questionnaire. The data collection started in June of 2018 and was finished in March of 2019.ResultsParticipants with higher psychological immune competency reported lower levels of burnout: emotional exhaustion (r = −0.478; p < 0.001), depersonalization (r = −0.459; p < 0.001) and personal accomplishment (r = 0.543; p < 0.001). Multiple linear stepwise regression analysis revealed the psychological immune competency to be a stable predictor of burnout on all three scales.ConclusionPsychological immune competency shows a strong relationship with scales of burnout syndrome and as such should be further examined due to development of successful intervention and prevention programs. 相似文献
8.
9.
Patrick Demkowicz BS Renelle Pointdujour-Lim MD Sofia Miguez BA Yesung Lee BS Bailey S. C. L. Jones BS Christopher A. Barker MD Marcus Bosenberg MD PhD David H. Abramson MD Alexander N. Shoushtari MD Harriet Kluger MD Jasmine H. Francis MD Mario Sznol MD Mathieu F. Bakhoum MD PhD 《Cancer》2023,129(20):3275-3286
10.